z-logo
Premium
Zn 2+ ‐Responsive Bimodal Magnetic Resonance Imaging and Fluorescence Imaging Agents and Their Interaction with Human Serum Albumin
Author(s) -
Xu YingQi,
Luo Jian,
Chen ZhongNing
Publication year - 2014
Publication title -
european journal of inorganic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.667
H-Index - 136
eISSN - 1099-0682
pISSN - 1434-1948
DOI - 10.1002/ejic.201402197
Subject(s) - gadolinium , chemistry , human serum albumin , fluorescence , crystallography , denticity , nephrogenic systemic fibrosis , nuclear magnetic resonance , crystal structure , biochemistry , physics , organic chemistry , quantum mechanics
The gadolinium(III) complexes Gd L1 and Gd L2 were designed as Zn 2+ ‐responsive bimodal magnetic resonance imaging (MRI) and fluorescence imaging probes. Upon binding to Zn 2+ ions, Gd L1 exhibits a bidentate or tridentate mode to form heterodinuclear Gd L1 Zn or heterotrinuclear (Gd L1 ) 2 Zn, whereas Gd L2 binds to the Zn 2+ ion only in a bidentate mode to form (Gd L2 ) 2 Zn. The gadolinium(III) complexes derived from both H 3 L1 and H 3 L2 exhibit remarkable interactions with human serum albumin (HSA) at both site I and site II, which result in significant enhancements of the relaxivity and remarkable improvements of T 1 ‐weighted imaging contrast. In the presence of HSA, both the relaxivity ( r 1 ) and fluorescence exhibit 300 % enhancement with a clear blueshift of the fluorescence for Gd L1 Zn, which is ascribed to direct binding to HSA through the formation of a Zn–HSA coordination bond. In contrast, the presence of HSA induces smaller relaxivity increases for Gd L1 (155 %), (Gd L1 ) 2 Zn (183 %), Gd L2 (192 %), and (Gd L2 ) 2 Zn (181 %); these increases are ascribed to weaker hydrophobic interactions or stereospecificity with HSA. The contrast of T 1 ‐weighted phantom MR images of these gadolinium(III) complexes in human serum (HS) is much improved relative to that in 4‐(2‐hydroxyethyl)‐1‐piperazineethanesulfonic acid (HEPES) buffer solutions.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here